James Anderson

Stock price provided by Lang & Schwarz

Showing transactions by James Anderson in Adaptimmune Therapeutics plc.

Quarter	Type	Shares before	Shares after	Change	Price range
2024-Q4	Sell	17M	12M	-5M	€0.55–€0.87
2024-Q3	Buy	15M	17M	+1.6M	€0.85–€1.29
2024-Q2	Sell	16M	15M	-723K	€0.81–€1.38
2024-Q1	Sell	16M	16M	-40K	€0.61–€1.61
2023-Q4	Sell	17M	16M	-1.2M	€0.37–€0.71
2023-Q3	Sell	17M	17M	-29K	€0.67–€0.89
2023-Q2	Buy	17M	17M	+64K	€0.79–€1.35
2023-Q1	Sell	17M	17M	-58K	€0.95–€2.08
2022-Q4	Buy	15M	17M	+2.5M	€1.09–€2.46
2022-Q3	Sell	15M	15M	-656K	€1.05–€2.36
2022-Q2	Sell	15M	15M	-59K	€1.26–€2.06
2022-Q1	Buy	14M	15M	+1.6M	€1.58–€3.52
2021-Q4	Buy	13M	14M	+931K	€3.04–€4.88
2021-Q3	Buy	12M	13M	+1.1M	€2.88–€5.60
2021-Q2	Buy	11M	12M	+229K	€3.16–€4.74
2021-Q1	Buy	10M	11M	+1.1M	€3.90–€5.85
2020-Q4	Buy	7.1M	10M	+3.3M	€3.32–€7.25
2020-Q3	Buy	5.3M	7.1M	+1.8M	€6.40–€9.35
2020-Q2	Buy	4.4M	5.3M	+936K	€2.32–€10.40
2020-Q1	Buy	4.3M	4.4M	+66K	€1.04–€4.48
2019-Q4	Buy	4.2M	4.3M	+123K	€0.67–€1.32
2019-Q3	Buy	4.1M	4.2M	+21K	€1.25–€3.52
2019-Q2	Buy	3.8M	4.1M	+305K	€2.84–€4.52
2019-Q1	Buy	3.7M	3.8M	+140K	€3.22–€5.15
2018-Q4	Buy	3.4M	3.7M	+282K	€3.24–€12.00
2018-Q3	Buy	3M	3.4M	+384K	€7.20–€11.40
2018-Q2	Buy	2.6M	3M	+468K	€8.50–€11.80
2018-Q1	Buy	1.9M	2.6M	+645K	€5.82–€9.80
2017-Q4	Buy	1.4M	1.9M	+541K	€5.51–€7.42
2017-Q3	Buy	1.3M	1.4M	+56K	€3.84–€7.38
2017-Q2	Buy	921K	1.3M	+402K	€3.87–€5.85
2016-Q3	Buy	430K	921K	+491K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors